Clinical indications for the albumin use: Still a controversial issue

European Journal of Internal Medicine

Volumn 24, Issue 8, 2013, Pages 721-728

  Caraceni, Paolo ^a   Domenicali, Marco ^a   Tovoli, Alessandra ^a   Napoli, Lucia ^a   Ricci, Carmen Serena ^a   Tufoni, Manuel ^a   Bernardi, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Albumin; Ascites; Fluid resuscitation; Liver cirrhosis; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; DIURETIC AGENT; HUMAN SERUM ALBUMIN; PLASMA SUBSTITUTE; TERLIPRESSIN; VASOCONSTRICTOR AGENT;

ABDOMINAL SURGERY; ADULT RESPIRATORY DISTRESS SYNDROME; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASCITES; BACTERIAL PERITONITIS; BRAIN ISCHEMIA; BURN; CAPILLARY PERMEABILITY; CARDIOVASCULAR DISEASE; CHEMICAL STRUCTURE; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; CRYSTALLOID; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG METABOLISM; DRUG TRANSPORT; ENDOTHELIUM; ENTEROPATHY; EVIDENCE BASED MEDICINE; FLUID BALANCE; FLUID RESUSCITATION; GRAFT VERSUS HOST REACTION; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; HYPOALBUMINEMIA; HYPONATREMIA; HYPOVOLEMIA; IMMUNOMODULATION; KERNICTERUS; KIDNEY FAILURE; LIVER CIRRHOSIS; LONG TERM CARE; MALNUTRITION; NEPHROTIC SYNDROME; NUTRITIONAL SUPPORT; ONCOTIC PRESSURE; PANCREATITIS; PARACENTESIS; PLASMAPHERESIS; PRESCRIPTION; PROTEIN BINDING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT INDICATION;

ALBUMIN; ASCITES; FLUID RESUSCITATION; HEPATORENAL SYNDROME; HRS; HSA; HUMAN SERUM ALBUMIN; ICU; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; NITRIC OXIDE; NO; POST-PARACENTESIS CIRCULATORY DYSFUNCTION; PPCD; SBP; SEPSIS; SPONTANEOUS BACTERIAL PERITONITIS; TNF-Α; TUMOR NECROSIS FACTOR-Α;

ASCITES; FLUID THERAPY; HEPATORENAL SYNDROME; HUMANS; HYPOALBUMINEMIA; LIVER CIRRHOSIS; PERITONITIS; RENAL INSUFFICIENCY; SERUM ALBUMIN; WATER-ELECTROLYTE IMBALANCE;

EID: 84889640990     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.05.015     Document Type: Review

References (73)

1. S. Sugio, A. Kashima, S. Mochizuki, M. Noda, and K. Kobayashi Crystal structure of human serum albumin at 2.5 A resolution Protein Eng 12 1999 439 446
2. M. Fasano, S. Curry, E. Terreno, M. Galliano, G. Fanali, and P. Narciso The extraordinary ligand binding properties of human serum albumin IUBMB Life 57 2005 787 796
3. G. Fanali, A. di Masi, V. Trezza, M. Marino, M. Fasano, and P. Ascenzi Human serum albumin: from bench to bedside Mol Aspects Med 33 2012 209 290
4. T.W. Evans Review article: albumin as a drug-biological effects of albumin unrelated to oncotic pressure Aliment Pharmacol Ther 16 2002 6 11
5. J.P. Nicholson, M.R. Wolmarans, and G.R. Park The role of albumin in critical illness Br J Anaesth 85 2000 599 610
6. R. Garcia-Martinez, P. Caraceni, M. Bernardi, P. Gines, V. Arroyo, and R. Jalan Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications Hepatology 2013 10.1002/hep.26338 [[Epub ahead of print]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23423799. Accessed 2013, Mar 2]
7. R. Jalan, K. Schnurr, R.P. Mookerjee, S. Sen, L. Cheshire, and S. Hodges Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality Hepatology 50 2009 555 564
8. K. Oettl, and R.E. Stauber Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties Br J Pharmacol 151 2007 580 590
9. E. Van Belle, J. Dallongeville, E. Vicaut, A. Degrandsart, C. Baulac, and G. Montalescot Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study Am Heart J 159 2010 570 576
10. E. Bourdon, N. Loreau, and D. Blache Glucose and free radicals impair the antioxidant properties of serum albumin FASEB J 13 1999 233 244
11. P. Faure, N. Wiernsperger, C. Polge, A. Favier, and S. Halimi Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin Clin Sci (Lond) 114 2008 251 256
12. M.L. Wratten, L. Sereni, and C. Tetta Oxidation of albumin is enhanced in the presence of uremic toxins Ren Fail 23 2001 563 571
13. J. Himmelfarb, and E. McMonagle Albumin is the major plasma protein target of oxidant stress in uremia Kidney Int 60 2001 358 363
14. K. Oettl, V. Stadlbauer, F. Petter, J. Greilberger, C. Putz-Bankuti, and S. Hallström Oxidative damage of albumin in advanced liver disease Biochim Biophys Acta 1782 2008 469 473
15. R. Stauber, W. Spindelboeck, J. Haas, C. Putz-Bankuti, V. Stadlbauer, and C. Lackner Human nonmercaptalbumin-2: a novel prognostic marker in chronic liver failure Ther Apher Dial 2013 10.1111/1744-9987.12024 [[Epub ahead of print]. Available from: http://http://onlinelibrary.wiley.com. Accessed 2013, May 7]
16. 3 + Eur J Biochem 220 1994 193 200
17. M. Sokołowska, M. Wszelaka-Rylik, J. Poznański, and W. Bal Spectroscopic and thermodynamic determination of three distinct binding sites for Co(II) ions in human serum albumin J Inorg Biochem 103 2009 1005 1013
18. J.F. Keaney, D.I. Simon, J.S. Stamler, O. Jaraki, J. Scharfstein, and J.A. Vita NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties J Clin Invest 91 1993 1582 1589
19. S.B. Kim, H.S. Chi, J.S. Park, C.D. Hong, and W.S. Yang Effect of increasing serum albumin on plasma D-dimer, von Willebrand factor, and platelet aggregation in CAPD patients Am J Kidney Dis 33 1999 312 317
20. H. Kitano, H. Fukui, Y. Okamoto, E. Kikuchi, M. Matsumoto, and M. Kikukawa Role of albumin and high-density lipoprotein as endotoxin-binding proteins in rats with acute and chronic alcohol loading Alcohol Clin Exp Res 20 1996 73A 76A
21. T.-A. Chen, Y.-C. Tsao, A. Chen, G.-H. Lo, C.-K. Lin, and H.-C. Yu Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis Scand J Gastroenterol 44 2009 619 625
22. R. Qiao, A. Siflinger-Birnboim, H. Lum, C. Tiruppathi, and A.B. Malik Albumin and Ricinus communis agglutinin decrease endothelial permeability via interactions with matrix Am J Physiol 265 1993 C439 C446
23. J.D. Lang, M. Figueroa, P. Chumley, M. Aslan, J. Hurt, and M.M. Tarpey Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium Anesthesiology 100 2004 51 58
24. J.H. Henriksen, O. Siemssen, J.J. Krintel, A. Malchow-Møller, F. Bendtsen, and H. Ring-Larsen Dynamics of albumin in plasma and ascitic fluid in patients with cirrhosis J Hepatol 34 2001 53 60
25. W.G. Rector, F. Ibarra, K. Openshaw, and J.C. Hoefs Ascites kinetics in cirrhosis: relationship to plasma-ascites hydrostatic-oncotic balance and intensity of renal sodium retention J Lab Clin Med 107 1986 412 419
26. P. Ginès, and R.W. Schrier Renal failure in cirrhosis N Engl J Med 361 2009 1279 1290
27. S. Møller, and J.H. Henriksen Cardiovascular complications of cirrhosis Postgrad Med J 85 2009 44 54
28. M. Bernardi, C. Maggioli, and G. Zaccherini Human albumin in the management of complications of liver cirrhosis Crit Care 16 2012 211
29. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis J Hepatol 53 2010 397 417
30. B.A. Runyon Management of adult patients with ascites due to cirrhosis: update 2012 Available from: http://www.aasld.org [Accessed 2013, May 9]
31. L. Ruiz-del-Arbol, A. Monescillo, W. Jimenéz, A. Garcia-Plaza, V. Arroyo, and J. Rodés Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis Gastroenterology 113 1997 579 586
32. P. Ginès, L. Titó, V. Arroyo, R. Planas, J. Panés, and J. Viver Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis Gastroenterology 94 1988 1493 1502
33. F. Salerno, S. Badalamenti, E. Lorenzano, P. Moser, and P. Incerti Randomized comparative study of hemaccel vs. Albumin infusion after total paracentesis in cirrhotic patients with refractory ascites Hepatology 13 1991 707 713
34. A. Ginès, G. Fernández-Esparrach, A. Monescillo, C. Vila, E. Domènech, and R. Abecasis Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis Gastroenterology 111 1996 1002 1010
35. J. Sola-Vera, J. Miñana, E. Ricart, M. Planella, B. González, and X. Torras Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites Hepatology 37 2003 1147 1153
36. M. Bernardi, P. Caraceni, R.J. Navickis, and M.M. Wilkes Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials Hepatology 55 2012 1172 1181
37. A. Rimola, G. García-Tsao, M. Navasa, L.J. Piddock, R. Planas, and B. Bernard Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club J Hepatol 32 2000 142 153
38. A. Follo, J.M. Llovet, M. Navasa, R. Planas, X. Forns, and A. Francitorra Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis Hepatology 20 1994 1495 1501
39. P. Sort, M. Navasa, V. Arroyo, X. Aldeguer, R. Planas, and L. Ruiz-del-Arbol Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 1999 403 409
40. P. Tandon, and G. Garcia-Tsao Bacterial infections, sepsis, and multiorgan failure in cirrhosis Semin Liver Dis 28 2008 26 42
41. S.H. Sigal, C.M. Stanca, J. Fernandez, V. Arroyo, and M. Navasa Restricted use of albumin for spontaneous bacterial peritonitis Gut 56 2007 597 599
42. R. Terg, A. Gadano, M. Cartier, P. Casciato, R. Lucero, and A. Muñoz Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study Liver Int 29 2009 415 419
43. M. Poca, M. Concepción, M. Casas, C. Alvarez-Urturi, J. Gordillo, and V. Hernández-Gea Role of albumin treatment in patients with spontaneous bacterial peritonitis Clin Gastroenterol Hepatol 10 2012 309 315
44. A. De Araujo, A. De Barros Lopes, G. Rossi, G.V. Da Silva, P. Ananias, and S. Ness Low-dose albumin in the treatment of spontaneous bacterial peritonitis: should we change the standard treatment? Gut 61 2012 1371 1372
45. F. Salerno, R.J. Navickis, and M.M. Wilkes Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials Clin Gastroenterol Hepatol 11 2013 123 130 [e1]
46. F. Salerno, A. Gerbes, P. Ginès, F. Wong, and V. Arroyo Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis Gut 56 2007 1310 1318
47. A.J. Sanyal, T. Boyer, G. Garcia-Tsao, F. Regenstein, L. Rossaro, and B. Appenrodt A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome Gastroenterology 134 2008 1360 1368
48. M. Martín-Llahí, M.-N. Pépin, M. Guevara, F. Díaz, A. Torre, and A. Monescillo Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study Gastroenterology 134 2008 1352 1359
49. R. Ortega, P. Ginès, J. Uriz, A. Cárdenas, B. Calahorra, and D. De Las Heras Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study Hepatology 36 2002 941 948
50. P. Angeli, R. Volpin, G. Gerunda, R. Craighero, P. Roner, and R. Merenda Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide Hepatology 29 1999 1690 1697
51. C. Alessandria, A. Ottobrelli, W. Debernardi-Venon, L. Todros, M.T. Cerenzia, and S. Martini Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study J Hepatol 47 2007 499 505
52. L.L. Gluud, K. Christensen, E. Christensen, and A. Krag Terlipressin for hepatorenal syndrome Cochrane Database Syst Rev 9 2012 CD005162 10.1002/14651858.CD005162.pub3 [Available from: http://www.ncbi.nlm.nih.gov/ pubmed/22972083. Accessed 2013, May 2]
53. P. Gentilini, V. Casini-Raggi, G. Di Fiore, R.G. Romanelli, G. Buzzelli, and M. Pinzani Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial J Hepatol 30 1999 639 645
54. R.-G. Romanelli, G. La Villa, G. Barletta, F. Vizzutti, F. Lanini, and U. Arena Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial World J Gastroenterol 12 2006 1403 1407
55. M. Guevara, C. Terra, A. Nazar, and E. Solà Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study J Hepatol 57 2012 759 765
56. P. Ginès, and M. Guevara Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management Hepatology 48 2008 1002 1010
57. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers BMJ 317 1998 235 240
58. M.M. Wilkes, and R.J. Navickis Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials Ann Intern Med 135 2001 149 164
59. P. Alderson, F. Bunn, C. Lefebvre, W.P.A. Li, L. Li, and I. Roberts Human albumin solution for resuscitation and volume expansion in critically ill patients Cochrane Database Syst Rev 2004 CD001208 [Available from: http://www.ncbi.nlm.nih.gov/pubmed/15495011. Accessed 2013, May 2]
60. S. Finfer, R. Bellomo, N. Boyce, J. French, J. Myburgh, and R. Norton A comparison of albumin and saline for fluid resuscitation in the intensive care unit N Engl J Med 350 2004 2247 2256
61. Human albumin solution for resuscitation and volume expansion in critically ill patients Cochrane Database Syst Rev 2011 CD001208 10.1002/14651858.CD001208.pub3 [Available from: http://www.ncbi.nlm.nih.gov/ pubmed/21975732. Accessed 2013, May 3]
62. J. Myburgh, D.J. Cooper, S. Finfer, R. Bellomo, R. Norton, and N. Bishop Saline or albumin for fluid resuscitation in patients with traumatic brain injury N Engl J Med 357 2007 874 884
63. S. Finfer, S. McEvoy, R. Bellomo, C. McArthur, J. Myburgh, and R. Norton Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis Intensive Care Med 37 2011 86 96
64. A. Delaney, A. Dan, J. McCaffrey, and S. Finfer The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis Crit Care Med 39 2011 386 391
65. R.P. Dellinger, M.M. Levy, A. Rhodes, D. Annane, H. Gerlach, and S.M. Opal Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012 Intensive Care Med 39 2013 165 228
66. R. Bañares, F. Nevens, F.S. Larsen, R. Jalan, A. Albillos, and M. Dollinger Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial Hepatology 57 2012 1153 1162
67. S. Sen, R. Williams, and R. Jalan Emerging indications for albumin dialysis Am J Gastroenterol 100 2005 468 475
68. B. Schaefer, and C.P. Schmitt The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children Pediatr Nephrol 2012 [[in press; Epub ahead of print]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23179193. Accessed 2013, May 6]
69. F. Mirici-Cappa, P. Caraceni, M. Domenicali, E. Gelonesi, B. Benazzi, and G. Zaccherini How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure World J Gastroenterol 17 2011 3479 3486
70. M. Tanzi, M. Gardner, M. Megellas, S. Lucio, and M. Restino Evaluation of the appropriate use of albumin in adult and pediatric patients Am J Health Syst Pharm 60 2003 1330 1335
71. M.J. Tarín Remohí, A. Sánchez Arcos, B. Santos Ramos, J. Bautista Paloma, and M.D. Guerrero Aznar Costs related to inappropriate use of albumin in Spain Ann Pharmacother 34 2000 1198 1205
72. I. Debrix, D. Combeau, F. Stephan, A. Benomar, and A. Becker Clinical practice guidelines for the use of albumin: results of a drug use evaluation in a Paris hospital. Tenon Hospital Paris Pharm World Sci 21 1999 11 16
73. E. Vargas, V. De Miguel, A. Portolés, C. Avendaño, M.I. Ambit, and A. Torralba Use of albumin in two Spanish university hospitals Eur J Clin Pharmacol 52 1997 465 470